|
Index of reports
> Cases resulting in other serious reactions (46)
> Cases with Breast Cancer Metastatic (9)
Below is the selection of adverse event reports related to Estratest (Esterified Estrogens) that includes cases resulting in other serious reactions where reactions include breast cancer metastatic.
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Prempro
Medroxyprogesterone
Estratest
Premarin
Provera
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Estrace
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Conjugated Estrogens
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Estratest
Dosage: unknown
Indication: Hormone Replacement Therapy
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female, weighing 77.2 kg (169.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Estratest
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Estrogen NOS
Medroxyprogesterone Acetate
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Cycrin
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Premarin
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Provera
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Prempro
Indication: Menopausal Symptoms
Medroxyprogesterone Acetate
Cenestin
Estratest
Premarin
Provera
Adverse event in receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient:
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 2000-12-01
End date: 2001-07-01
Prempro
Dosage: unspecified dose regimen
Administration route: Oral
Start date: 2001-10-01
End date: 2003-10-01
Norethindrone Acetate
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-01-01
End date: 1997-01-01
Estratest
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 2001-07-01
End date: 2001-10-01
Provera
Dosage: unspecified
Indication: Hormone Replacement Therapy
Start date: 1997-01-01
End date: 2000-12-01
Provera
Dosage: unspecified
Administration route: Oral
Start date: 2001-07-01
End date: 2001-10-01
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-16
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 1999-05-01
Estratest
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 2000-03-01
End date: 2002-03-01
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 1999-05-01
End date: 2000-02-01
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-10-08
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Estrogens
Provera
Estrace
Estratest
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-02
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Prempro
Indication: Hormone Replacement Therapy
Estratest
Adverse event in 56 year old female receiving Estratest (Esterified Estrogens)
Reported by a physician from United States on 2007-06-05
Patient: 56 year old female, weighing 63.5 kg (139.7 pounds)
Adverse reactions / side effects: Hysteroscopy, Liver Disorder, Fibrocystic Breast Disease, Uterine Leiomyoma, Liver Function Test Abnormal, Oedema Peripheral, Breast Microcalcification, Depression, Breast Hyperplasia, Pain in Extremity, Radiotherapy, Malignant Breast Lump Removal, Osteopenia, Hepatic Steatosis, Breast Cancer Metastatic, Uterine Dilation and Curettage, Menometrorrhagia
Suspect drug(s):
Estraderm
Dosage: 0.05mg
Indication: Hormone Replacement Therapy
Start date: 1990-12-01
End date: 1992-01-01
Premphase 14 / 14
Dosage: 0.625mg
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 1999-10-01
Cycrin
Dosage: 10mg unk
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 1992-01-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1990-01-01
End date: 2002-01-01
Premarin
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1993-07-01
End date: 1993-01-01
Provera
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1991-12-01
End date: 1996-01-01
Ogen
Indication: Hormone Replacement Therapy
Start date: 1999-01-01
End date: 2002-01-01
Estrace
Dosage: unk, unk
Indication: Hormone Replacement Therapy
Start date: 1993-01-01
End date: 1996-01-01
Prempro
Indication: Menopause
Start date: 2001-12-01
End date: 2002-01-01
Other drugs received by patient: Paxil; Xanax; Pamelor
|
